Showing results (181-190 of 247) with videos related to
Sort By:
Pageof 25
Journal of Clinical Gastroenterology|September 12, 2009
The epidemiology and clinical characteristics of patients with newly diagnosed alcohol-related liver disease: results from population-based surveillanceAndre N Sofair, Vaughn Barry, M Michele Manos, et al.Hepatology (Baltimore, Md.)|May 4, 2011
Hepatitis C virus-infected women have a higher risk of advanced fibrosis and graft loss after liver transplantation than menJennifer C Lai, Elizabeth C Verna, Robert S Brown, et al.Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 19, 2019
Underestimation of Liver Transplantation for Alcoholic Hepatitis in the National Transplant DatabaseBrian P Lee, Gene Y Im, John P Rice, et al.The Journal of Infectious Diseases|December 12, 2013
Monocyte activation by interferon α is associated with failure to achieve a sustained virologic response after treatment for hepatitis C virus infectionDennis J Hartigan-O'Connor, Din Lin, James C Ryan, et al.Journal of Hepatology|November 23, 2006
Clinical evaluation (Phase I) of a human monoclonal antibody against hepatitis C virus: safety and antiviral activityEithan Galun, Norah A Terrault, Rachel Eren, et al.Transplantation|February 26, 2015
Telaprevir- and Boceprevir-based Triple Therapy for Hepatitis C in Liver Transplant Recipients With Advanced Recurrent Disease: A Multicenter StudyElizabeth C Verna, Varun Saxena, James R Burton, et al.Journal of Hepatology|May 8, 2014
A US multicenter study of hepatitis C treatment of liver transplant recipients with protease-inhibitor triple therapyJames R Burton, Jacqueline G O'Leary, Elizabeth C Verna, et al.Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|December 31, 2005
Protective antibody levels and dose requirements for IV 5% Nabi Hepatitis B immune globulin combined with lamivudine in liver transplantation for hepatitis B-induced end stage liver diseaseRolland C Dickson, Norah A Terrault, Michael Ishitani, et al.Transplantation|July 29, 2003
Kidney and liver transplantation in human immunodeficiency virus-infected patients: a pilot safety and efficacy studyPeter G Stock, Michelle E Roland, Laurie Carlson, et al.Hepatology (Baltimore, Md.)|August 3, 2007
Outcomes of donor evaluation in adult-to-adult living donor liver transplantationJames F Trotter, Karen A Wisniewski, Norah A Terrault, et al.Pageof 25